HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meilan Zhang Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

11/2016TTF1, in the Form of Nanoparticles, Inhibits Angiogenesis, Cell Migration and Cell Invasion In Vitro and In Vivo in Human Hepatoma through STAT3 Regulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meilan Zhang Research Topics

Disease

13Neoplasms (Cancer)
01/2024 - 11/2016
3Stomach Neoplasms (Stomach Cancer)
07/2023 - 10/2022
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023 - 02/2018
3Autoimmune Diseases (Autoimmune Disease)
03/2009 - 05/2007
2Chronic Obstructive Pulmonary Disease (COPD)
06/2023 - 01/2021
2Lymphoma (Lymphomas)
05/2023 - 05/2007
2Carcinogenesis
10/2022 - 09/2022
2Fibrosis (Cirrhosis)
10/2021 - 02/2021
2Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2021 - 02/2021
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 05/2008
2Philadelphia Chromosome
01/2021 - 02/2018
2Liver Neoplasms (Liver Cancer)
01/2020 - 11/2016
2Prion Diseases (Transmissible Spongiform Encephalopathies)
12/2019 - 01/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024
1Cognitive Dysfunction
12/2023
1Nasopharyngeal Carcinoma
05/2023
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2023
1Leukemia
01/2023
1T-Cell Leukemia (Leukemia, T Cell)
01/2023
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023
1Neuroblastoma
05/2022
1Cytokine Release Syndrome
01/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1Bone Marrow Failure Disorders
01/2022
1Fanconi Anemia (Fanconi's Anemia)
01/2022
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2022
1Genomic Instability
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Hypersensitivity (Allergy)
01/2022
1Neoplasm Metastasis (Metastasis)
12/2021
1Breast Neoplasms (Breast Cancer)
12/2021
1Asthma (Bronchial Asthma)
10/2021
1Hypoxia (Hypoxemia)
01/2020
1Scrapie
12/2019
1Hepatocellular Carcinoma (Hepatoma)
03/2018
1Infections
01/2015
1Medically Unexplained Symptoms
03/2012
1Psoriasis (Pustulosis Palmaris et Plantaris)
03/2009
1Skin Diseases (Skin Disease)
03/2009

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2020
5Circular RNAIBA
06/2023 - 12/2021
4Long Noncoding RNAIBA
06/2023 - 01/2021
4Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2021
3Messenger RNA (mRNA)IBA
06/2023 - 12/2021
3MicroRNAs (MicroRNA)IBA
06/2023 - 12/2021
2EnzymesIBA
07/2023 - 01/2020
2RNA (Ribonucleic Acid)IBA
06/2023 - 05/2022
2Competitive Endogenous RNAIBA
06/2023 - 10/2022
2Immunoglobulins (Immunoglobulin)IBA
01/2023 - 09/2022
2Chimeric Antigen ReceptorsIBA
01/2022 - 01/2021
2Prion ProteinsIBA
12/2019 - 01/2018
2Monoclonal AntibodiesIBA
05/2008 - 05/2007
1Amyloid (Amyloid Fibrils)IBA
01/2024
1Sevoflurane (Ultane)FDA LinkGeneric
12/2023
1KetamineFDA LinkGeneric
12/2023
1Neuroprotective AgentsIBA
12/2023
1CalreticulinIBA
09/2023
1Oxygen (Dioxygen)IBA
07/2023
1Phosphatidylinositols (Phosphatidylinositol)IBA
05/2023
1EBV-encoded nuclear antigen 1IBA
05/2023
1CarcinogensIBA
05/2023
1Membrane Proteins (Integral Membrane Proteins)IBA
05/2023
1NF-kappa B (NF-kB)IBA
05/2023
1Chemokine ReceptorsIBA
05/2023
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2023
1TropomyosinIBA
01/2023
1venetoclaxIBA
01/2023
1larotrectinibIBA
01/2023
1Phosphotransferases (Kinase)IBA
01/2023
1LuciferasesIBA
05/2022
1DecitabineFDA Link
01/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022
1HomoharringtonineIBA
01/2022
1Transforming Growth Factor-beta Type II ReceptorIBA
10/2021
1atractylonIBA
10/2021
1OvalbuminIBA
10/2021
1indium-bleomycinIBA
02/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
02/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2021
1AntigensIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1Adenosine Triphosphate (ATP)IBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2020
1ginsenoside M1IBA
01/2020
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2018
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
11/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2016
1Anti-Bacterial Agents (Antibiotics)IBA
01/2015
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
03/2012
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
03/2009
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2009
1LigandsIBA
03/2009

Therapy/Procedure

7Therapeutics
01/2023 - 11/2016
4Immunotherapy
09/2023 - 01/2021
4Drug Therapy (Chemotherapy)
01/2023 - 12/2021
1Hematopoietic Stem Cell Transplantation
01/2023
1Induction Chemotherapy
01/2022